AUSTIN, Texas – Governor Greg Abbott and the Texas Department of State Health Services (DSHS) have announced the guiding principles for Texas’ COVID-19 vaccine allocation process, which will serve as a foundation for the state’s initial distribution for COVID-19 vaccines expected as early as next month.
These principles have been established by the Expert Vaccine Allocation Panel (EVAP) and created by DSHS to make recommendations on vaccine allocation decisions – including identifying groups that should be vaccinated first to provide the most protection to vulnerable populations and critical state resources.
Texas will initially allocate COVID-19 vaccines based on the following criteria:
• Protecting health care workers who fill a critical role in caring for and preserving the lives of COVID-19 patients and maintaining the health care infrastructure for all who need it.
• Protecting frontline workers who are at greater risk of contracting COVID-19 due to the nature of their work providing critical services and preserving the economy.
• Protecting vulnerable populations who are at greater risk of severe disease and death if they contract COVID-19.
• Mitigating health inequities due to factors such as demographics, poverty, insurance status and geography.
• Data-driven allocations using the best available scientific evidence and epidemiology at the time, allowing for flexibility for local conditions.
• Geographic diversity through a balanced approach that considers access in urban and rural communities and in affected ZIP codes.
• Transparency through sharing allocations with the public and seeking public feedback.
EVAP has recommended, and the Commissioner of Health John Hellerstedt has approved, health care workers likely to provide direct care for COVID-19 patients and other vulnerable residents to be the first group to receive the vaccine. This includes staff at hospitals and long-term care facilities, emergency medical services and home health care workers. As part of its ongoing work, EVAP will make recommendations on how and when to roll out vaccine to other critical groups.